Taken together, these results indicated that miR-21 suppresses FOXO1 and its transcriptional target Bim directly by binding to the 3′-UTR of FOXO1 and indirectly by activating the PI3K/AKT pathway in DLBCL. The gene discussed is BCL2L11; the disease is diffuse large B-cell lymphoma.